| 2065 | HSAP00P0000265395 | -2.606 | 7.582 | -8.666 | 2.143e-07 | 0.0001303 | 7.379 | ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | ENSG00000065361 | 190151, 607598 | 2065 | NM_001982 |
| 2475 | HSAP00P0000003713 | -1.333 | 8.028 | -3.162 | 0.006121 | 0.07449 | -2.537 | MTOR | mechanistic target of rapamycin (serine/threonine kinase) | ENSG00000198793 | 601231 | 2475 | NM_004958 |
| 2631 | HSAP00P0000162588 | -2.29 | 9.384 | -6.58 | 6.761e-06 | 0.001032 | 4.08 | GBAS | glioblastoma amplified sequence | ENSG00000146729 | 603004 | 2631 | NM_001483 |
| 3066 | HSAP00P0000149822 | -1.926 | 8.656 | -5.61 | 4.108e-05 | 0.003162 | 2.325 | HDAC2 | histone deacetylase 2 | ENSG00000196591 | 605164 | 3066 | NM_001527 |
| 367 | HSAP00P0000427044 | -3.63 | 10.01 | -8.646 | 2.211e-07 | 0.0001332 | 7.35 | AR | androgen receptor | ENSG00000169083 | 176807, 300068, 300633, 312300, 313200, 313700 | 367 | M73069 |
| 5036 | HSAP00P0000265443 | -1.809 | 10.2 | -7.973 | 6.346e-07 | 0.0002496 | 6.352 | PA2G4 | proliferation-associated 2G4, 38kDa | ENSG00000170515 | 602145 | 5036 | U87954 |
| 545 | HSAP00P0000091555 | -1.56 | 7.214 | -3.407 | 0.003665 | 0.05439 | -2.046 | ATR | ataxia telangiectasia and Rad3 related | ENSG00000175054 | 210600, 601215 | 545 | NM_001184 |